Biolife Solutions (BLFS) Shares Outstanding (2010 - 2026)

Biolife Solutions (BLFS) has reported Shares Outstanding (Entity) for 17 consecutive years, with $48.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 2.18% year-over-year to $48.9 million in Q2 2026; TTM through Jun 2026 was $48.9 million, a 2.18% increase from a year earlier, with the FY2025 full-year figure at $48.2 million, up 2.75% from the prior year.
• Shares Outstanding (Entity) was $48.9 million for Q2 2026 at Biolife Solutions, roughly flat from $48.8 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $48.9 million in Q2 2026 and troughed at $42.3 million in Q1 2022.
• A 5-year average of $45.6 million and a median of $45.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) rose 25.86% in 2022 and grew 2.13% in 2023, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $42.8 million in 2022, then grew by 5.45% to $45.2 million in 2023, then gained by 3.85% to $46.9 million in 2024, then climbed by 2.75% to $48.2 million in 2025, then climbed by 1.43% to $48.9 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $48.9 million (Q2 2026), $48.8 million (Q1 2026), and $48.2 million (Q4 2025), per Business Quant data.